Jane Street’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Jane Street’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-57,314	Closed	-$572K	–	10589
2022 Q3	$572K	Sell	57,314 -264	-0.5%	-$2.62K	﹤0.01%	6441
2022 Q2	$568K	Buy	57,578 +218	+0.4%	+$2.15K	﹤0.01%	6494
2022 Q1	$564K	Buy	57,360 +16	+0%	+$157	﹤0.01%	7241
2021 Q4	$559K	Buy	57,344 +30	+0.1%	+$293	﹤0.01%	7052
2021 Q3	$561K	Buy	57,314 +200	+0.4%	+$1.94K	﹤0.01%	7074
2021 Q2	$553K	Buy	57,114 +1,974	+4%	+$19.2K	﹤0.01%	7047
2021 Q1	$532K	Buy	+55,140	New	+$535K	﹤0.01%	6699

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street's PKBO Position: Q4 2022 in Review

Jane Street sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 57,314 shares — an estimated $572K sold.

Jane Street first reported a position in PKBO in Q1 2021 and held it in 7 quarters. The position peaked at $572K in Q3 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Jane Street reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Jane Street sold 57,314 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $572K.
Jane Street first reported a position in Peak Bio, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Jane Street's Peak Bio, Inc. Common Stock position peaked at $572K in Q3 2022.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.